Position
Parametrica Management Ltd in Fate Therapeutics Inc
Back to the book · All holders of FATE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.02K$0.98 → $1.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 18.5K | $18.2K | — | — | — | 0.0% |
| Q1 2026 | 18.5K | $22.2K | $1.20 | $4.02K | −$0 | 0.0% |